The PROSPER trial

Lancet. 2003 Feb 1;361(9355):427; author reply 428.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Anticholesteremic Agents / pharmacology
  • Anticholesteremic Agents / therapeutic use*
  • Biomarkers / blood
  • C-Reactive Protein / drug effects*
  • C-Reactive Protein / metabolism
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / immunology
  • Cardiovascular Diseases / prevention & control*
  • Cholesterol, LDL / blood
  • Humans
  • Inflammation
  • Patient Selection
  • Pravastatin / pharmacology
  • Pravastatin / therapeutic use*
  • Predictive Value of Tests
  • Primary Prevention / methods
  • Risk Factors

Substances

  • Anticholesteremic Agents
  • Biomarkers
  • Cholesterol, LDL
  • C-Reactive Protein
  • Pravastatin